2024 ICD-10-CM Diagnosis Code D69.49

Other primary thrombocytopenia

ICD-10-CM Code:
D69.49
ICD-10 Code for:
Other primary thrombocytopenia
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:

Code Classification

  • Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
    (D50–D89)
    • Coagulation defects, purpura and other hemorrhagic conditions
      (D65-D69)
      • Purpura and other hemorrhagic conditions
        (D69)

D69.49 is a billable diagnosis code used to specify a medical diagnosis of other primary thrombocytopenia. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Amegakaryocytic thrombocytopenia
  • Autoimmune hemolytic anemia, autoimmune thrombocytopenia, primary immunodeficiency syndrome
  • Congenital cutaneous angiomatosis
  • Decreased megakaryocyte production
  • Kasabach-Merritt syndrome
  • Mediterranean thrombocytopenia
  • Megakaryocytic aplasia
  • Megakaryocytic thrombocytopenia
  • Primary thrombocytopenia
  • Thrombocytopenia due to defective platelet production
  • Thrombocytopenia due to diminished platelet production
  • Thrombocytopenic purpura

Clinical Classification

Clinical Information

  • Acquired Thrombotic Thrombocytopenic Purpura|Acquired ADAMTS13 Deficiency|Acquired TTP

    thrombotic thrombocytopenic purpura for which the cause is not present at birth.
  • Congenital Thrombotic Thrombocytopenic Purpura|Congenital ADAMTS-13 Deficiency|Congenital ADAMTS13 Deficiency|Congenital TTP

    thrombotic thrombocytopenic purpura for which the cause is present from birth.
  • Grade 3 Thrombotic Thrombocytopenic Purpura, CTCAE|Grade 3 Thrombotic thrombocytopenic purpura

    laboratory findings with clinical consequences (e.g., renal insufficiency, petechiae)
  • Grade 4 Thrombotic Thrombocytopenic Purpura, CTCAE|Grade 4 Thrombotic thrombocytopenic purpura

    life-threatening consequences, (e.g., cns hemorrhage or thrombosis/embolism or renal failure)
  • Grade 5 Thrombotic Thrombocytopenic Purpura, CTCAE|Grade 5 Thrombotic thrombocytopenic purpura

    death
  • Primary Immune Thrombocytopenia|ITP|ITP|ITP|ITP|Idiopathic Thrombocytopenia|Idiopathic Thrombocytopenia Purpura|Idiopathic Thrombocytopenic Purpura|Idiopathic Thrombocytopenic Purpura|Idiopathic Thrombocytopenic Purpura|Idiopathic Thrombocytopenic Purpura|Immune Thrombocytopenia|Immune Thrombocytopenic Purpura|Immune thrombocytopenic purpura|idiopathic thrombocytopenic purpura|immune thrombocytopenic purpura

    acquired thrombocytopenia of unknown cause, characterized by immune-mediated destruction of normal platelets. it affects both children and adults. it manifests with petechiae, purpura, and overt bleeding. based upon the duration of the disease, it is classified as newly diagnosed (from diagnosis until 3 months), persistent (3-12 months), and chronic (lasting for more than 12 months).
  • Thrombocytopenic Purpura

    purpura associated with a reduction in circulating blood platelets which can result from a variety of factors.
  • Thrombotic Thrombocytopenic Purpura, CTCAE|Thrombotic Thrombocytopenic Purpura|Thrombotic thrombocytopenic purpura

    a disorder characterized by the presence of microangiopathic hemolytic anemia, thrombocytopenic purpura, fever, renal abnormalities and neurological abnormalities such as seizures, hemiplegia, and visual disturbances. it is an acute or subacute condition.
  • Thrombotic Thrombocytopenic Purpura|Moschowitz Disease|TTP|TTP|Thrombotic thrombocytopenic purpura

    a coagulation disorder characterized by extensive formation of thrombi in small blood vessels throughout the body due to low levels of adamts13 protein, and resulting in consumption of circulating platelets, which is characterized by thrombocytopenia, anemia, neurologic changes, and sometimes fever and renal dysfunction.

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.


Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Megakaryocytic hypoplasia
  • Primary thrombocytopenia NOS

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Convert D69.49 to ICD-9-CM

  • ICD-9-CM Code: 287.30 - Prim thrombocytopen NOS
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.
  • ICD-9-CM Code: 287.39 - Prim thrombocytopen NEC
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Patient Education


Platelet Disorders

Platelets, also known as thrombocytes, are blood cells. They form in your bone marrow, a sponge-like tissue in your bones. Platelets play a major role in blood clotting. Normally, when one of your blood vessels is injured, you start to bleed. Your platelets will clot (clump together) to plug the hole in the blood vessel and stop the bleeding. You can have different problems with your platelets:

  • If your blood has a low number of platelets, it is called thrombocytopenia. This can put you at risk for mild to serious bleeding. The bleeding could be external or internal. There can be various causes. If the problem is mild, you may not need treatment. For more serious cases, you may need medicines or blood or platelet transfusions.
  • If your blood has too many platelets, you may have a higher risk of blood clots.
    • When the cause is unknown, this is called thrombocythemia. It is rare. You may not need treatment if there are no signs or symptoms. In other cases, people who have it may need treatment with medicines or procedures.
    • If another disease or condition is causing the high platelet count, it is thrombocytosis. The treatment and outlook for thrombocytosis depends on what is causing it.
  • Another possible problem is that your platelets do not work as they should. For example, in von Willebrand Disease, your platelets cannot stick together or cannot attach to blood vessel walls. This can cause excessive bleeding. There are different types of in von Willebrand Disease; treatment depends on which type you have.

NIH: National Heart, Lung, and Blood Institute


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.